DK131324B - Fremgangsmåde til fremstilling af et lægemiddel i form af en klar, steril vandig opløsning. - Google Patents

Fremgangsmåde til fremstilling af et lægemiddel i form af en klar, steril vandig opløsning.

Info

Publication number
DK131324B
DK131324B DK232472AA DK232472A DK131324B DK 131324 B DK131324 B DK 131324B DK 232472A A DK232472A A DK 232472AA DK 232472 A DK232472 A DK 232472A DK 131324 B DK131324 B DK 131324B
Authority
DK
Denmark
Prior art keywords
medicament
clear
preparation
aqueous solution
sterile aqueous
Prior art date
Application number
DK232472AA
Other languages
Danish (da)
English (en)
Other versions
DK131324C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html
Inventor
N A Stevenson
G Wardell
Original Assignee
Fisons Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26250625&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK131324(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Fisons Ltd filed Critical Fisons Ltd
Publication of DK131324B publication Critical patent/DK131324B/da
Application granted granted Critical
Publication of DK131324C publication Critical patent/DK131324C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Otolaryngology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK232472AA 1971-05-12 1972-05-10 Fremgangsmåde til fremstilling af et lægemiddel i form af en klar, steril vandig opløsning. DK131324B (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB1452971 1971-05-12
GB5716971A GB1399834A (en) 1971-05-12 1971-12-09 Pharmaceutical compositions

Publications (2)

Publication Number Publication Date
DK131324B true DK131324B (da) 1975-06-30
DK131324C DK131324C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1975-11-24

Family

ID=26250625

Family Applications (1)

Application Number Title Priority Date Filing Date
DK232472AA DK131324B (da) 1971-05-12 1972-05-10 Fremgangsmåde til fremstilling af et lægemiddel i form af en klar, steril vandig opløsning.

Country Status (15)

Country Link
JP (1) JPS5425082B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU465305B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE (1) BE782981A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA1000201A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CY (1) CY955A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (2) DE2266025A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK131324B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (1) FR2139872B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (1) GB1399834A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HK (1) HK69276A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IE (1) IE36337B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (1) IL39286A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
MY (1) MY7700080A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NL (1) NL177386B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SE (1) SE396011B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2230358A2 (en) * 1973-05-25 1974-12-20 Fisons Ltd Cromoglycate contg. solns. - contg. a second therapeutically active cpd. e.g. an antihistamine
DE2634908A1 (de) * 1974-11-09 1977-04-14 Fisons Ltd Mittel zur behandlung chronischer haut- oder augenerkrankungen
DE3700379A1 (de) * 1987-01-08 1988-07-21 Mann Gerhard Chem Pharm Fab Konservierte augentropfen mit einem gehalt an cromoglicinsaeure
GB8819490D0 (en) * 1988-08-16 1988-09-21 Fisons Plc Pharmaceutical devices
AT410894B (de) * 1988-03-22 2003-08-25 Fisons Plc Verwendung einer wässerigen lösung von natriumcromoglycat und chlorbutol
DE68915203T2 (de) * 1988-03-22 1994-09-22 Fisons Plc, Ipswich, Suffolk Pharmazeutische Mischungen.
FR2649890A1 (fr) * 1988-03-22 1991-01-25 Fisons Plc Compositions pharmaceutiques
EP0933084A4 (en) * 1995-12-27 2000-07-12 Showa Pharm Chem Ind AQUEOUS AGENTS CONTAINING CROMOGLYN
DE19614823A1 (de) 1996-04-15 1997-10-16 Mann Gerhard Chem Pharm Fab Ophthalmische Zusammensetzung mit verlängerter Verweilzeit am Auge
EP0938896A1 (en) * 1998-01-15 1999-09-01 Novartis AG Autoclavable pharmaceutical compositions containing a chelating agent
JP5785353B2 (ja) * 2004-02-27 2015-09-30 大正製薬株式会社 眼科用剤
JP5992293B2 (ja) * 2012-10-31 2016-09-14 大正製薬株式会社 眼科用剤
PL426472A1 (pl) * 2018-07-27 2020-02-10 Kalbarczyk Grzegorz Arkona Laboratorium Farmakologii Stomatologicznej Zastosowanie medyczne bromku domifenu oraz kompozycja do leczenia stanów zapalnych w obrębie jamy ustnej

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1144905A (en) * 1965-03-25 1969-03-12 Fisons Pharmaceuticals Ltd Substituted bis-(2-carboxy-chromonyl-oxy) derivatives and preparation and pharmaceutical compositions thereof
GB1190194A (en) * 1966-07-05 1970-04-29 Fisons Pharmaceuticals Ltd Bis-Phenoxy Compounds and Chromanone and Chromone Derivatives

Also Published As

Publication number Publication date
HK69276A (en) 1976-11-12
DE2223237A1 (de) 1972-12-14
CY955A (en) 1978-12-22
BE782981A (fr) 1972-11-03
AU465305B2 (en) 1975-09-25
JPS5425082B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1979-08-25
IL39286A0 (en) 1972-06-28
MY7700080A (en) 1977-12-31
AU4208072A (en) 1973-11-15
DK131324C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1975-11-24
FR2139872B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1975-10-31
IE36337B1 (en) 1976-10-13
CA1000201A (en) 1976-11-23
GB1399834A (en) 1975-07-02
DE2223237C2 (de) 1985-01-17
FR2139872A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1973-01-12
IL39286A (en) 1975-02-10
DE2266025A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1985-03-07
IE36337L (en) 1972-11-12
NL7206251A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1972-11-14
SE396011B (sv) 1977-09-05
NL177386B (nl) 1985-04-16

Similar Documents

Publication Publication Date Title
CH550582A (de) Ophthalmologische laserstrahlbehandlungsanlage.
DK131324B (da) Fremgangsmåde til fremstilling af et lægemiddel i form af en klar, steril vandig opløsning.
NL7500171A (nl) Sterilisatie-oplossing.
SE392472B (sv) Fysiologiskt oskadlig, vattensvellbar epoxidhaltig polymer med formaga att bilda komplex med polyvalenta metallkatjoner samt forfarande for dess framstellning
DK129291B (da) Fremgangsmåde til fremstilling af et kimfattigt, flydedygtigt pancreatinpræparat.
DK137784B (da) Fremgangsmåde til fremstilling af et kosmetisk præparat, til anvendelse på den menneskelige hud.
NO141590C (no) Absorberende engangsartikler.
DK123595B (da) Analogifremgangsmåde til fremstilling af benzensulfonylurinstoffer eller fysiologisk uskadelige salte deraf.
NL166470C (nl) Werkwijze ter bereiding van een geneesmiddel met bronchi-verwijdende en de afscheiding van maagzuur tegengaande werking, alsmede werkwijze ter bereiding van daarin toegepaste pyrimidinonverbindingen.
DK130976B (da) Fremgangsmåde til fremstilling af 2,5-dimethyl-furan-3-carboxylsyreestere.
CH552000A (fr) Procede de preparation d'oxazoles 2,4,5-trisubstitues.
NO772996L (no) 2-amino-4h-pyraner, fremgangsm}te til deres fremstilling samt deres anvendelse som legemiddel.
DK127778B (da) Fremgangsmåde til fremstilling af 3',4'-dideoxy-kenamycin B.
FI52096C (fi) Menetelmä analgeettisesti aktiivisten 2,3-dihydrotiatsolo(3.2.a)pyrimi diini-5-onien valmistamiseksi
DK132329B (da) Fremgangsmåde til fremstilling af cardenolid-3,alfa-/2'-desoxy-glycosider/.
DK132305B (da) Fremgangsmåde til fremstilling af en stabil, klar vitaminholdig jernopløsning.
DK130967B (da) Analogifremgangsmåde til fremstilling af 2-(3,4-dikloranilin)-kinolizinbromid.
DK134518B (da) Analogifremgangsmåde til fremstilling af 4beta-alkoxy-4alfa-(3'-hydroxyphenyl)-3alfa,5alfa-propanopiperidin-derivater.
DK136152B (da) Analogifremgangsmåde til fremstilling af 1-aminomethylderivater af 2,2-diarylclopropaner eller syreadditionssalte deraf.
DK133812B (da) Fremgangsmåde til fremstilling af hydrohalogenider af 2,2'-anhydro-1-beta-D-arabinofuranosyl-5-fluorcytosin.
DK137190B (da) Fremgangsmåde til fremstilling af 6beta-amino-2,2-dimetylpenam-3alfa-karboxylsyre.
FI51351C (fi) Menetelmä lääkeaineena käytettävien 1-dimetyylifosfinyylialakyyli-5-fe nyyli-1,2,4,5-tetrahydro-3H-1,5-bentsodiatsepiini-2,4-dionien valmista miseksi.
DK120076B (da) Analogifremgangsmåde til fremstilling af N-substituerede N'-guanylformamidiner eller syreadditionssalte deraf, til anvendelse som lægemidler.
CH548205A (de) Ampulle, insbesondere injektionsampulle.
DK144012C (da) Analogifremgangsmaade til fremstilling af n1-piperonyl-n4-3,7,11-trimetyl-2,6,10-dodekatrienylpiperazin eller terapeutisk acceptable syreadditionssalte deraf

Legal Events

Date Code Title Description
PUP Patent expired